Efficacy of Novalac AD in the treatment of infantile rotavirus enteritis.

Author: Yu-Hua LIU ¹ ; Jing LI
Author Information

1. Department of Pediatrics, Beijing Friendship Hospital Affiliate of Capital University of Medical Sciences, Beijing 100050, China.
Publication Type:Clinical Trial
MeSH: Antiviral Agents; therapeutic use; Enteritis; drug therapy; virology; Humans; Infant; Infant, Newborn; Rotavirus; drug effects; pathogenicity; Rotavirus Infections; drug therapy; virology
From: Chinese Journal of Experimental and Clinical Virology 2010;24(2):145-146
CountryChina
Language:Chinese
Abstract:
OBJECTIVETo observe clinical efficacy of Novalac AD in infantile rotavirus enteritis.
METHODS20 infants with rotavirus enteritis but without dehydration and/or acidosis were selected to be fed by Novalac AD for one week.
RESULTSEffective rate was 100%. All 20 subjects stool turned normal and systemic symptoms disappeared after treatment, with 17 within 48 h (85%,17/20) and 3 within 72 h (15%, 3/20).
CONCLUSIONNovalac AD has a significant effect on infantile rotavirus enteritis.